Cardiogram has developed a cardiovascular health decision support application, which enables users to manage chronic health conditions and identify undiagnosed conditions
Cardiogram demonstrated to identify atrial fibrillation with 97% accuracy in a joint study with the University of California. (Credit: Raman Oza from Pixabay)
ilumivu has wrapped up the acquisition of US-based Cardiogram to support the commercialisation of its personalised decision support solutions.
Established in 2016, Cardiogram has developed a cardiovascular health decision support application, which enables users to manage chronic health conditions and identify undiagnosed conditions.
By using wearable devices, users can have a continuous cardiovascular monitoring through the company’s mobile app.
Cardiogram has designed and trained a neural network using millions of cardiovascular data points and record to detect medical conditions such as atrial fibrillation, diabetes, hypertension, and sleep apnea.
The Cardiogram mobile app is said to be compatible with Apple iOS and Android smartphones, as well as Apple Watch, WearOS by Google, Fitbit, Garmin, and Samsung wearables.
Cardiogram demonstrated the detection of atrial fibrillation with 97% accuracy and both sleep apnea and hypertension at greater than 82% accuracy, in a joint study with the University of California.
Ilumivu president David Smith said: “We believe that, as a result of this merger and financing, these remote decision support capabilities can be enhanced to be useful in improving care for individuals more broadly, including seniors and their caregivers covered by Medicare Advantage.”
Ilumivu has also completed a Series A funding round with Health Catalyst Capital to support the acquisition, as well as expand its personalised decision support solutions.
Established in 2009, ilumivu offers digital health SaaS software to support healthcare research and monitor patients with multiple health conditions.
The company’s digital health platform is developed to monitor various diseases and conditions such as autism, Alzheimer’s, heart/blood pressure/strokes and cardiovascular diseases, cancer, and chronic lung disease.
ilumivu senior vice president Harish Kilaru said: “Patients with cardiovascular disease often lack tools to monitor their heart health outside the doctor’s office. Cardiogram empowers users to better understand their heart health patterns and to share the data with their doctors and caregivers.
“With many COVID-19 patients becoming long-haulers and experiencing cardiovascular symptoms and over 30 million adults diagnosed with heart disease, remote monitoring of heart conditions is increasingly necessary.”